[Clinical practice guidelines for the treatment of hemorrhoid disease].
Abramowitz
L
L
Godeberge
P
P
Staumont
G
G
Soudan
D
D
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003107:Colorectal Surgery / Q000379:methods* / Q000592:standards / Q000639:trends; D004145:Diosmin / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005544:Forecasting; D006484:Hemorrhoids / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000601:surgery*; D006801:Humans; D009017:Morbidity; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D015995:Prevalence; D012307:Risk Factors; D013256:Steroids; D017131:Thrombectomy; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D013256:Steroids; D004145:Diosmin